Kopran Research Laboratories Profile
Key Indicators
- Authorised Capital ₹ 25.00 Cr
as on 17-07-2024
- Paid Up Capital ₹ 22.50 Cr
as on 17-07-2024
- Company Age 38 Year, 4 Months
- Last Filing with ROC 31 Mar 2023
- Open Charges ₹ 168.35 Cr
as on 17-07-2024
- Revenue 15.00%
(FY 2023)
- Profit -83.28%
(FY 2023)
- Ebitda -68.65%
(FY 2023)
- Net Worth -1.92%
(FY 2023)
- Total Assets 1.54%
(FY 2023)
About Kopran Research Laboratories
The Corporate was formerly known as Kopran Formulations Private Limited. The Company is engaged in the Pharma Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2023. It's a company limited by shares with an authorized capital of Rs 25.00 Cr and a paid-up capital of Rs 22.50 Cr.
The company currently has active open charges totaling ₹168.35 Cr.
The Key Managerial Personnel (KMP) at Kopran Research Laboratories Limited India are Lekha Jogi as CFO and Chandni Shah as Company Secretary. Rakesh Doshi, Vandana Somani, Chandra Singhi, and Two other members serve as directors at the Company.
- CIN/LLPIN
U24230MH1986PLC040601
- Company No.
040601
- Company Classification
Public Limited Indian Non-Government Company
- Incorporation Date
12 Aug 1986
- Date of AGM
13 Sep 2023
- Date of Balance Sheet
31 Mar 2023
- Listing Status
Unlisted
- ROC Code
Roc Mumbai
Industry
Company Details
- Location
Mumbai, Maharashtra, India
- Telephone
- Email Address
- Website
- Social Media-
Who are the key members and board of directors at Kopran Research Laboratories?
Executive Team (2)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Lekha Jogi | CFO | 15-Dec-2020 | Current |
Chandni Shah | Company Secretary | 08-Jun-2021 | Current |
Board Members(5)
Name | Designation | Appointment Date | Status |
---|---|---|---|
Sunita Banerji | Director | 01-Mar-2016 | Current |
Rakesh Doshi | Director | 14-Nov-2017 | Current |
Vandana Somani | Director | 18-Feb-2015 | Current |
Chandra Singhi | Whole-Time Director | 24-Jun-2015 | Current |
Mamta Biyani | Director | 14-Nov-2017 | Current |
Financial Performance and Corporate Structure Insights of Kopran Research Laboratories.
Kopran Research Laboratories Limited, for the financial year ended 2023, experienced significant growth in revenue, with a 15% increase. The company also saw a substantial fall in profitability, with a 83.28% decrease in profit. The company's net worth dipped by a decrease of 1.92%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
---|---|---|---|---|---|---|---|
Total Revenue |
| ||||||
Revenue from Operations |
| ||||||
Total Assets |
| ||||||
Profit or Loss |
| ||||||
Net Worth |
| ||||||
EBITDA |
|
What is the Ownership and Shareholding Structure of Kopran Research Laboratories?
In 2023, Kopran Research Laboratories had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
- Apurva Caplease And Finance Private LimitedActive 28 years 6 months
Vandana Somani is a mutual person
Charges (Loans)
Lender | Amount | Status |
---|---|---|
Others Creation Date: 04 May 2023 | ₹28.00 Cr | Open |
Yes Bank Limited Creation Date: 16 Mar 2021 | ₹11.50 Cr | Open |
State Bank Of India Creation Date: 30 Jul 2020 | ₹45.35 Cr | Open |
How Many Employees Work at Kopran Research Laboratories?
Kopran Research Laboratories has a workforce of 492 employees as of Apr 03, 2024. Unlock access to detailed historical data on individuals associated with the company, including employment records, contributions to the Employees' Provident Fund Organization (EPFO), and other related insights.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Kopran Research Laboratories, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Kopran Research Laboratories's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.